Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Serymun Yeast GmbH has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner, HINES, JANA A, who is the busiest examiner for the portfolio with 1 pending office action. The prosecution is occurring within 1 distinct art unit, reflecting a specific technical focus for the company's current filing.
The presence of 1 distinct examiner means that the company's immediate interactions with the USPTO are limited to a single individual. Practitioners can focus their strategy on the specific requirements of HINES, JANA A rather than managing multiple examiner styles. The fact that the busiest examiner pending count of 1 is equal to the total pending office actions confirms that there is no distribution of work across other examiners at this time.
Because the portfolio is limited to 1 distinct art unit, the company does not need to navigate different procedural norms across multiple USPTO departments. This streamlined profile suggests a narrow engagement with the patent office. The 1 pending office action represents the entirety of the company's current active prosecution in the Biotechnology & Pharmaceuticals sector.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HINES, JANA A | 1 | 53.0% | +39.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18036852 | Yeast Platform for the Production of Vaccines | HINES, JANA A | — |
| Art Unit | Apps |
|---|---|
| 1600 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18036852 | Yeast Platform for the Production of Vaccines | HINES, JANA A | 1600 | §112 | Non-Final OA | — | Pending | May 12, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial